For over half a century, research funded by Massachusetts Lions Eye Research Fund, Inc., has helped people with a myriad of eye diseases.
MLERF Provides “Seed” Money
Agencies such as the Federal Government typically only fund research that has progressed to the point where it has demonstrated viable outcomes.
Before research scientists can receive research grants and funding from groups like the National Science Foundation (NSF) or the National Institute of Health (NIH), the science must already be proven. Some say it is a catch-22.
If a scientist has a theory about a possible cure for a particular eye disease, before he or she can apply for funding from the NSF or NIH, he/she has to show the results of preliminary research into the viability of the theory.
Researchers require “Seed Money” to be able to advance their research from a “promising idea” to “demonstrated outcomes.”
Massachusetts Lions Eye Research Fund, Inc., provides seed money in the form of grants to reputable institutions that have a track record of pursuing promising research endeavors.
This is where we help to take the ideas of today to create the cures of tomorrow.
As a result of the preliminary MLERF funding, researchers are often able to apply for grants from the NSF or NIH that provide a 10:1 (or higher) return on the original MLERF investment.
MLERF Funds Cutting-edge Research
MLERF has had a long and fruitful partnership with many of the top eye research centers in the world.
One of the first research grants ever funded by MLERF stimulated research that found the cause of retrolental fibroplasia (also known as Blind Baby disease), now known as Retinopathy of Prematurity.
Below is a partial list of the institutions that MLERF grants have supported: